Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

K&B Management Achieves Exemplary Results for Treating Cellulite with QWO

The FDA-approved, non-surgical cellulite treatment is the first-of-its-kind prescription medicine used to treat moderate to severe cellulite in women.


News provided by

K&B Management

Apr 20, 2021, 09:00 ET

Share this article

Share toX

Share this article

Share toX


CHARLOTTE, N.C., April 20, 2021 /PRNewswire-PRWeb/ -- K&B Management, a Charlotte-based aesthetics consulting firm, announced that it has successfully attained above-average results with QWO, a first and only FDA-approved cellulite treatment injectable used to treat moderate to severe cellulite in the buttocks of adult women. The practice is one of the first to introduce the non-surgical cellulite treatment to its patients and will continue to use this as a viable treatment option moving forward.

QWO, also known as collagenase clostridium, histolyticum-aaes, addresses a primary structural cause of cellulite by targeting the fibrous septae. Made from collagenases enzymes, the non-surgical, prescription injectable treatment works by releasing fibrous bands, redistributing fat cells, and stimulating the growth of new collagen.

“We’ve had outstanding results with QWO and have seen the onset of cellulite greatly decrease with as little as three treatment session," comments Founding Partner, Dr. Gaurav Bharti MD, FACS.

Post this

"K&B Management is constantly reviewing new and innovative treatment options that can elevate the quality of aesthetics treatment for our patients," comments Founding Partner, Dr. Gaurav Bharti MD, FACS. "We've had outstanding results with QWO and have seen the onset of cellulite greatly decrease with as little as three treatment sessions."

The main causes of cellulite and its infamous dimples include the thinning of the skin, the accumulation of fat cells that push up against the skin, and the interaction between the fibrous connective cords and the underlying muscle. Cellulite can be a stubborn problem to treat that requires numerous, repeated office visits and a mix of treatment procedures over time. QWO injections are quick and require no long recovery time, with results seen as quickly as three treatment sessions over the course of two months.

"We are excited that K&B Management is one of the first to offer QWO and have found that our patients have greatly benefited from the treatments," says Co-Owner and Managing Partner, Dr. Bill Kortesis MD, FACS. "As always, we remain committed to ensuring our patients receive the best care and options available in the industry."

K&B Management strives to provide innovative, high quality treatment options to patients and its partnering aesthetic practices. The introduction and adoption of QWO is yet another one of K&B Management's investments in quality aesthetic treatment options.

###

K&B Management K&B Management, founded in 2019 by renowned plastic surgeons, Dr. Bill Kortesis MD, FACS and Dr. Gaurav Bharti MD, FACS, offers strategic growth and consulting services to practices and providers in the medical aesthetic space. Charlotte-based with a national reach, K&B Management aims to facilitate the highest standard of aesthetic medicine by bridging the gap between providers and the industry. Through K&B Management's innovative, tactical approach, each provider has the means to thrive and deliver optimal patient experiences.

Bill Kortesis MD, FACS
Dr. Bill Kortesis is a Castle Connolly Top Doctor and board-certified plastic surgeon who aims to foster and spearhead the next generation of aesthetic medicine. Dr. Kortesis has made huge milestones in the future of aesthetic medicine through the investment of innovative technologies and the training of future plastic surgeons in the highest level of surgical technique. As Co-Owner and Managing Partner of H/K/B Cosmetic Surgery, and Co-Founder of K&B Management, Dr. Kortesis passionately believes in the important of utilizing digital means to provide optimal patient care while producing excellent results in the aesthetic space.

Gaurav Bharti MD, FACS
Dr. Gaurav Bharti is a board-certified plastic surgeon who has been recognized by American Airlines magazine as one of the "Best Plastic Surgeons of America" and a Castle Connolly Top Doctor. Dr. Bharti is highly focused on furthering the medical aesthetics industry through innovative concepts to improve patient outcomes and contributing to cutting-edge advancements. As a fellow mentor to the next generation of aesthetic surgeons, he has continued to contribute his expertise and continued education as an influential speaker in the industry. Based out of Charlotte, North Carolina, Dr. Bharti practices at H/K/B Cosmetic Surgery, where he also acts as Co-Owner and Managing Partner. Additionally, he also serves as Co-Founder of practice growth consulting firm, K&B Management.

Media Contact

Rebecca Binny, MedShift, 3103349942, [email protected]

SOURCE K&B Management

Related Links

https://www.hkbsurgery.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.